Skip to main content
. 2011 Jun;11(2):279–284.

Table 3.

Immunohistochemical characteristics of tumours of patients with metastatic disease (n = 64)

Receptor Status Percentage
ER+ 35.1
PR+ 26.7
Her2neu+ 48.3
Luminal A(ER+,PR+,Her2neu−) 39.1
Luminal B (ER/PR+Her2neu+) 10.1
Basal-like (Triple -ve) 46.1
ER-ve,PR-ve, Her2neu+ 5.1